{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:59:44Z","timestamp":1765609184514},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1997,9,1]],"date-time":"1997-09-01T00:00:00Z","timestamp":873072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[1997,9]]},"DOI":"10.1016\/s0006-2952(97)00061-0","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T23:51:59Z","timestamp":1027641119000},"page":"541-544","source":"Crossref","is-referenced-by-count":62,"title":["Human ovarian cancer of the surface epithelium"],"prefix":"10.1016","volume":"54","author":[{"given":"Andrew","family":"Berchuck","sequence":"first","affiliation":[]},{"given":"Michael","family":"Carney","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0006-2952(97)00061-0_BIB1","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","article-title":"Characteristics relating to ovarian cancer risk. Collaborative analysis of twelve US case-control studies. II. Invasive epithelial ovarian cancers in white women","volume":"136","author":"Whittemore","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1289\/ehp.877335","article-title":"Ovarian tumors of the hen","volume":"73","author":"Fredrickson","year":"1987","journal-title":"Environ Health Perspect"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0002-9378(11)80044-X","article-title":"Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer","volume":"164","author":"Berchuck","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB4","first-page":"1537","article-title":"The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance","volume":"9","author":"Kohler","year":"1989","journal-title":"Anticancer Res"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0002-9378(91)90508-O","article-title":"Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factor","volume":"164","author":"Rodriguez","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","article-title":"Studies of HER-2\/neu proto-oncogene in human breast and ovarian cancer","volume":"244","author":"Slamon","year":"1989","journal-title":"Science"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB7","first-page":"4087","article-title":"Overexpression of HER-2\/neu is associated with poor survival in advanced epithelial ovarian cancer","volume":"50","author":"Berchuck","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0002-9378(12)90907-2","article-title":"Prognostic significance of HER-2\/neu expression in advanced ovarian cancer","volume":"168","author":"Rubin","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0090-8258(92)90051-J","article-title":"Neu protein overexpression in benign, borderline, and malignant ovarian neoplasms","volume":"44","author":"Kacinski","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB10","first-page":"6139","article-title":"K-ras activation in neoplasms of the human female reproductive tract","volume":"50","author":"Enomoto","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB11","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1126\/science.6695178","article-title":"Somatic activation of rasK gene in a human ovarian carcinoma","volume":"223","author":"Feig","year":"1984","journal-title":"Science"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB12","first-page":"265","article-title":"Evidence against ras activation in human ovarian carcinomas","volume":"4","author":"Haas","year":"1987","journal-title":"Mol Biol Med"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB13","first-page":"3103","article-title":"p53 and Ki-ras gene mutations in epithelial ovarian neoplasms","volume":"53","author":"Teneriello","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB14","first-page":"1489","article-title":"Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy","volume":"53","author":"Mok","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB15","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/ijc.2910500528","article-title":"c-myc overexpression in human primary ovarian tumors: Its relevance to tumor progression","volume":"50","author":"Tashiro","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB16","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/0002-9378(92)91697-9","article-title":"Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-\u03b2","volume":"166","author":"Berchuck","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB17","first-page":"255","article-title":"The role of peptide growth factors in epithelial ovarian cancer","volume":"75","author":"Berchuck","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0304-3835(90)90106-8","article-title":"Transforming growth factor-beta and ovarian carcinoma cells: Regulation of proliferation and surface antigen expression","volume":"51","author":"Marth","year":"1990","journal-title":"Cancer Lett"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB19","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/bjc.1992.140","article-title":"Transforming growth factor-\u03b2 mRNA expression in growth control of human ovarian carcinoma cells","volume":"65","author":"Bartlett","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB20","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/ijc.2910520516","article-title":"Transforming growth factor \u03b21 (TGF-\u03b21) inhibits growth of a human ovarian cancer cell line (OVCCR1) and is expressed in human ovarian tumors","volume":"52","author":"Jozan","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0925-4439(92)90061-Q","article-title":"Growth regulation of ovarian cancer cells by epidermal growth factor and transforming growth factors \u03b1 and \u03b21","volume":"1180","author":"Zhou","year":"1992","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/1097-0142(19940701)74:1<93::AID-CNCR2820740117>3.0.CO;2-P","article-title":"Effect of transforming growth factor-\u03b2 on proliferation of human ovarian cancer cells obtained from ascites","volume":"74","author":"Hurteau","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF02170882","article-title":"Unusual antiproliferative effects of transforming growth factors-\u03b2l and \u03b22 against primary cells from human tumors","volume":"1","author":"Daniels","year":"1989","journal-title":"Biotherapy"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB24","first-page":"2979","article-title":"Overexpression and mutation of p53 in epithelial ovarian cancer","volume":"51","author":"Marks","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB25","first-page":"643","article-title":"Mutation and overexpression of p53 in early-stage epithelial ovarian cancer","volume":"81","author":"Kohler","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB26","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1006\/gyno.1994.1037","article-title":"Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors","volume":"52","author":"Berchuck","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB27","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1093\/jnci\/85.18.1513","article-title":"Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer","volume":"85","author":"Kohler","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB28","first-page":"4961","article-title":"p53 gene mutations and protein accumulation in human ovarian cancer","volume":"90","author":"Kupryja\u0144czyk","year":"1993"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.7939630","article-title":"BRCA1 mutations in primary breast and ovarian carcinomas","volume":"266","author":"Futreal","year":"1994","journal-title":"Science"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jama.1995.03520310033026","article-title":"A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening","volume":"273","author":"Shattuck-Eidens","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/S0006-2952(97)00061-0_BIB32","first-page":"2998","article-title":"Mutation analysis of the BRCAI gene in ovarian cancers","volume":"55","author":"Takahashi","year":"1995","journal-title":"Cancer Res"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295297000610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295297000610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T15:35:22Z","timestamp":1555515322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295297000610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,9]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1997,9]]}},"alternative-id":["S0006295297000610"],"URL":"https:\/\/doi.org\/10.1016\/s0006-2952(97)00061-0","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[1997,9]]}}}